Gain Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DME CAPITAL MANAGEMENT, LP | 02/14/2025 | 566.13 K | $1.22 M | 0.00% | 2.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 267.42 K | $577.70 K | -1.67% | 1.01% |
| VANGUARD GROUP INC | 02/11/2025 | 177.08 K | $382.48 K | 21.94% | 0.67% |
| GOTHAM ASSET MANAGEMENT, LLC | 02/14/2025 | 158.16 K | $3.74 M | -52.73% | 0.60% |
| JONES FINANCIAL COMPANIES LLLP | 02/06/2025 | 98.25 K | $212.22 K | 83.64% | 0.37% |
| MARSHALL WACE, LLP | 02/13/2025 | 91.74 K | $198.16 K | 100.00% | 0.35% |
| MORGAN STANLEY | 02/14/2025 | 88.51 K | $191.19 K | 1,744.00% | 0.33% |
| BLACKROCK, INC. | 02/07/2025 | 86.06 K | $185.89 K | 1.34% | 0.32% |
| NORTHERN TRUST CORP | 02/14/2025 | 84.59 K | $182.71 K | 88.20% | 0.32% |
| STATE STREET CORP | 02/14/2025 | 71.14 K | $153.66 K | 106.57% | 0.27% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 54.50 K | $118.00 K | 100.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 46.91 K | $101.33 K | 100.00% | 0.18% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 35.82 K | $77.37 K | 0.00% | 0.14% |
| UBS GROUP AG | 02/14/2025 | 35.23 K | $76.09 K | 316.64% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 30.00 K | $64.81 K | 100.00% | 0.11% |
| ROYAL BANK OF CANADA | 02/14/2025 | 17.50 K | $38.00 K | 100.00% | 0.07% |
| BENEDICT FINANCIAL ADVISORS INC | 01/28/2025 | 16.00 K | $34.56 K | 100.00% | 0.06% |
| SANDHILL CAPITAL PARTNERS LLC | 02/13/2025 | 15.40 K | $33.26 K | 0.00% | 0.06% |
| SPROTT INC. | 02/04/2025 | 14.00 K | $30.24 K | 100.00% | 0.05% |
| CITADEL ADVISORS LLC | 02/14/2025 | 11.61 K | $25.08 K | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 02/14/2025 | 10.60 K | $22.90 K | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 02/14/2025 | 5.70 K | $12.31 K | 100.00% | 0.02% |
| CREEKMUR ASSET MANAGEMENT LLC | 02/12/2025 | 4.44 K | $9.59 K | 0.00% | 0.02% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 4.41 K | $9.53 K | 100.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 4.09 K | $8.82 K | 13.98% | 0.02% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 2.65 K | $5.72 K | 0.00% | 0.01% |
| CITIGROUP INC | 02/12/2025 | 2.00 K | $4.32 K | 100.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gain Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Gain Therapeutics, Inc.. The most heavily invested institutionals were:
DME Capital Management, LP: 566,130
GEODE CAPITAL MANAGEMENT, LLC: 267,421
VANGUARD GROUP INC: 177,075
Gotham Asset Management, LLC: 158,155
JONES FINANCIAL COMPANIES LLLP: 98,250
MARSHALL WACE, LLP: 91,738
7.48% of Gain Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.63 M shares in the last 24 months. This purchase volume represents approximately $4.98 M in transactions.